Skip to content

In the BioHarmony Drug Report Database

Liothyronine

Cytomel, Triostat (liothyronine) is a small molecule pharmaceutical. Liothyronine was first approved as Cytomel on 1982-01-01. It is used to treat autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, and thyrotoxicosis in the USA. The pharmaceutical is active against thyroid hormone receptor beta and thyroid hormone receptor alpha.
Trade Name Cytomel, Triostat
Common Name Liothyronine
Indication autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, thyrotoxicosis
Drug Class
Liothyronine
Get full access now